Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

TTP Death Linked to Elevated Troponin and Neurological Signs

Key clinical point: Neurological abnormalities and elevated troponin predict mortality in patients with thrombotic thrombocytopenic purpura (TTP).

Major finding: ADAMTS13 IgG antibody level, elevated troponin, and neurological abnormalities were all linked to an increased mortality risk.

Study details: A retrospective analysis of 475 patients with clinically suspected thrombotic thrombocytopenic purpura (TTP) from the U.K. registry (2009-2018).

Disclosures: The investigators reported having no conflicts of interest.

Citation:

A presentation from the annual meeting of the British Society for Haematology.